.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

The Role of Anti-Angiogenic Therapy in Lung Cancer

EP. 1: Dysregulated Angiogenesis in Cancer

February 15th 2016

EP. 2: Therapeutic Targeting Against Abnormal Tumor Vasculature

February 15th 2016

EP. 3: Use of Bevacizumab for Lung Cancer

February 15th 2016

EP. 4: Ramucirumab for Squamous or Nonsquamous Lung Cancer

February 15th 2016

EP. 5: Combining Therapies with Antiangiogenic Antibodies

February 15th 2016